D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Lowe's Companies
LOW
|
$591M |
| 2 |
NVIDIA
NVDA
|
$454M |
| 3 |
EQT Corp
EQT
|
$361M |
| 4 |
Citigroup
C
|
$332M |
| 5 |
CELG
Celgene Corp
CELG
|
$315M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$618M |
| 2 |
Dell
DELL
|
$463M |
| 3 |
IBM
IBM
|
$331M |
| 4 |
Amgen
AMGN
|
$284M |
| 5 |
Johnson & Johnson
JNJ
|
$250M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Healthcare | 13.01% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Financials | 10.39% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Badger Meter
BMI
$5.39B
| $201K | ﹤0.01% |
4,257
-183
| -4% | -$8.64K |
|
|
I
2327
DELISTED
INTELSAT S. A.
I
| $198K | ﹤0.01% |
+52,575
| New | +$198K |
|
2328
New Mountain Finance
NMFC
$1.13B
| $197K | ﹤0.01% |
14,978
-30,327
| -67% | -$399K |
|
|
ORIT
2329
DELISTED
Oritani Financial Corp. New
ORIT
| $196K | ﹤0.01% |
+12,800
| New | +$196K |
|
|
JMBA
2330
DELISTED
Jamba, Inc.
JMBA
| $195K | ﹤0.01% |
+22,789
| New | +$195K |
|
|
PGTI
2331
DELISTED
PGT, Inc.
PGTI
| $194K | ﹤0.01% |
+10,397
| New | +$194K |
|
2332
Destination XL Group
DXLG
$66.8M
| $192K | ﹤0.01% |
109,752
-1,892
| -2% | -$3.31K |
|
2333
Ecovyst
ECVT
$1.03B
| $192K | ﹤0.01% |
13,730
-532
| -4% | -$7.44K |
|
2334
Adverum Biotechnologies
ADVM
$73.9M
| $190K | ﹤0.01% |
+3,272
| New | +$190K |
|
|
CMCM
2335
Cheetah Mobile
CMCM
$196M
| $189K | ﹤0.01% |
2,823
-478
| -14% | -$32K |
|
|
PCMI
2336
DELISTED
PCM, Inc
PCMI
| $187K | ﹤0.01% |
+22,538
| New | +$187K |
|
|
AUO
2337
DELISTED
AU Optronics Corp
AUO
| $187K | ﹤0.01% |
41,021
+5,500
| +15% | +$25.1K |
|
|
DERM
2338
DELISTED
Dermira, Inc.
DERM
| $183K | ﹤0.01% |
22,904
-71,444
| -76% | -$571K |
|
|
HSTO
2339
DELISTED
Histogen Inc. Common Stock
HSTO
| $182K | ﹤0.01% |
155
-72
| -32% | -$84.5K |
|
2340
Solid Biosciences
SLDB
$428M
| $180K | ﹤0.01% |
+1,603
| New | +$180K |
|
|
AMRN
2341
Amarin Corp
AMRN
$317M
| $179K | ﹤0.01% |
2,972
-1,281
| -30% | -$77.2K |
|
|
CBIO
2342
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $177K | ﹤0.01% |
109
-1,416
| -93% | -$2.3M |
|
|
CMO
2343
DELISTED
Capstead Mortgage Corp.
CMO
| $176K | ﹤0.01% |
20,392
+8,787
| +76% | +$75.8K |
|
|
PVG
2344
DELISTED
PRETIUM RESOURCES INC.
PVG
| $175K | ﹤0.01% |
26,248
-63,742
| -71% | -$425K |
|
|
IMOS
2345
ChipMOS TECHNOLOGIES
IMOS
$620M
| $172K | ﹤0.01% |
+9,231
| New | +$172K |
|
|
BEL
2346
DELISTED
Belmond Ltd.
BEL
| $172K | ﹤0.01% |
+15,433
| New | +$172K |
|
2347
ODP
ODP
$668M
| $170K | ﹤0.01% |
7,905
-53,667
| -87% | -$1.15M |
|
2348
Northfield Bancorp
NFBK
$498M
| $169K | ﹤0.01% |
10,800
-2,384
| -18% | -$37.3K |
|
2349
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $167K | ﹤0.01% |
15,141
-22,965
| -60% | -$253K |
|
2350
Pixelworks
PXLW
$46.2M
| $166K | ﹤0.01% |
3,581
+285
| +9% | +$13.2K |
|